Xi'an Janssen Pharmaceutical Ltd., the biggest subsidiary of US healthcare giant Johnson & Johnson in the Chinese mainland, is expected to see days be harder in the future. It was established by Janssen-Cilag, a subsidiary of Jonson & ...
Clinical-stage biopharmaceutical company Pharmacyclics' new drug application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, has been accepted by the US FDA for two B-cell malignancy indications. ...
Tags: Solvay Group, Medicine
Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers. The Janssen Research & Development will manage compound ...
Symphony Environmental Technologies Plc, global specialists in advanced plastics and tyre recycling technologies, is pleased to announce that it has signed a five year supply and marketing agreement with Janssen Pharmaceutica, a division of ...
The colorful display of mechanical gears and light and shadow of the exhibit Clockwork Snow was designed by the design team Frank Tjepkema and Leonie Janssen. Yet nothing like the flick Clockwork Orange, this upbeat magical ...
NedSense enterprises n.v. (NYSE Euronext Amsterdam: NEDSE) announced that specialist carpet designer and manufacturer MARCJANSSEN has selected the LOFT4Brands shared solution to offer a virtual showroom to its clients and design partners. ...
The US FDA has approved Janssen Biotech's Simponi ARIA (golimumab) for infusion to treat moderately to severely active rheumatoid arthritis (RA). Simponi ARIA is the only fully-human anti-tumor necrosis factor (TNF)-alpha infusible ...
Janssen Research & Development is seeking FDA approval for use of ibrutinib in the treatment of previously treated patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). The ...
Tags: FDA Approval, Janssen
US-based Mylan Pharmaceuticals has introduced generic equivalent to Micronor tablets, 0.35mg (28-day cycle) indicated for the prevention of pregnancy in the US. Norethindrone Tablets USP, 0.35mg, are the generic version of Janssen ...
Tags: Generic Micronor Tablets, Medicine
US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...
Tags: Johnson&Johnson, Medicine
Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel drug targets mediated by the bacterial ecosystem living within the human gut to treat ulcerative colitis. Under the collaboration, Janssen ...
Tags: Microbiome Drug, Medicine
Johnson & Johnson (J&J) Innovation has opened the new California Innovation Center to build early stage collaborations with emerging companies in science and technology and advance healthcare. The new centre has the flexibility to adapt ...
Tags: Health, Medicine, healthcare
Reusable plastic water bottles may be good for the environment, but a new study shows they might be bad for your health. There's a possibility that the chemical found in plastic water bottles, baby bottles and the lining of many food, ...
Tags: baby bottle, child bottle
Mitsubishi Tanabe Pharma is seeking manufacturing and marketing approval of TA-7284 (generic name: canagliflozin) in Japan. The company filed a new drug application to the Ministry of Health, Labor and Welfare in Japan for TA-7284 to ...
Tags: Mitsubishi, canagliflozin
Johnson & Johnson's Pharmaceuticals unit Janssen is planning to submit more than 10 new products for regulatory approval and extend the brand pipeline of 25 existing drugs by 2017. The late stage products to be submitted for approval ...
Tags: Johnson&Johnson, New Drugs